Moderna, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for MRNA, updated each market day.
MRNA AI Sentiment
AI sees no strong directional signal for Moderna, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Moderna, Inc. Common Stock
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Sector
Exchange
Market Cap
$20,336,974,283
Cap Tier
Employees
4,700
Headquarters
CAMBRIDGE, MA
Listed Since
Dec. 7, 2018
Website
MRNA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MRNA Volatility
Moderna, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
